Seventh Framework Programme and European Commission logos

Advancing the development of life-saving drugs for cardiovascular diseases

CarTarDis

Cardiovascular disease (CVD) is the leading cause of death in the world, yearly accounting for over 17 million deaths. To improve the life-expectancy of CVD patients, a multi-partner consortium has been brought together funded by the European Union to take on the challenge to advance the drug development  for the treatment of cardiovascular diseases.

CVD affects the heart and surrounding blood vessels and can take many forms, such as high blood pressure, coronary artery disease, heart disease and stroke. Progression is  slow without clear symptoms warning for this life-threatening disease. Although the introduction of statins has reduced the morbidity and mortality of atherosclerosis by 30%, still a major residual cardiovascular risk remains, which necessitates the development of new medicines. The goal of the EU project CarTarDis (Cardiovascular Target Discovery) is to advance the development of CVD medicines by discovery and validation of novel therapeutics targets to CVD.

EU website

News